Page results
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
This page provides information about anaesthesia for children having proton beam therapy.
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
-
This page explains what autologous stem cell transplant is and includes information about our stem cell transplant service and process, the care patients will receive and what to expect after the transplant.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
Thalamotomy for Tremor using Transcranial MRI-Guided Focused Ultrasound patient information leaflet
-
The diagnostic haematology clinics at UCLH perform comprehensive blood testing, including blood film examination, immunophenotyping and molecular testing.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
Patient information for patients who have been recommended to use a Mepilex® dressing on their skin that has broken down due to your radiotherapy or proton beam therapy treatment.
File results
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments
-
FOI/2022/0161 - Referral to treatment waiting times
-
FOI/2022/0163 - Ongoing staff absence due to COVID-19
-
FOI/2022/0166 - Routine GP referrals made to Cardiology, Gynaecology and Neurology
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0216 - Inventory management system
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0227 - Number of cancer trackers and cancer MDT co-ordinators at Trust